Abstract
Simple Summary Peptide receptor radionuclide therapy (PRRT) with [Lu-177]Lu-DOTA-TATE is used to treat gastroenteropancreatic neuroendocrine tumours (......
小提示:本篇文献需要登录阅读全文,点击跳转登录